Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Status
- COMPLETED
- Phase
- PHASE2
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
- Status
- COMPLETED
- Phase
- PHASE1
QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide in Treating Patients With Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2